← Leaderboards
Dean Yaw Li
University Of Utah
$21,127,919
Attributed
$21,127,919
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$21,127,919 · 13
VA$0 · 1
By mechanism
R01$15,967,911 · 8
T32$2,272,518 · 1
U54$1,780,660 · 1
K02$538,650 · 1
S10$443,980 · 1
K08$124,200 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Shannon J Odelberg$4,968,511
- Kevin J Whitehead$2,290,676
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsPathway InteractionsAngiogenesisEndothelial CellsCellsMolecularPlaySignal TransductionBaseEndotheliumCytokineSignal PathwayReceptorResponseProteinsIn VivoAnimal ModelPermeabilityMediatingSmall MoleculeGenesKnockout MicePathogenesisCell Communication
Grant awards (66)
Training in Cardiovascular Research$5,097
T32 · FY2017 · HL · contact PI
Opposing Mechanisms of Stabilizing and Destabilizing Receptors$372,500
R01 · FY2016 · HL · contact PI
Endothelial Toll-Like Receptor Signaling and Inflammation$372,500
R01 · FY2016 · HL · contact PI
Identifying a nodal point for G alpha q signaling in eye disease$340,838
R01 · FY2016 · CA · contact PI
Pathophysiology of a Genetic Vascular Disease$0
I01 · FY2016 · VA · contact PI
Endothelial Toll-Like Receptor Signaling and Inflammation$366,912
R01 · FY2015 · HL · contact PI
Opposing Mechanisms of Stabilizing and Destabilizing Receptors$366,912
R01 · FY2015 · HL · contact PI
Training in Cardiovascular Research$343,574
T32 · FY2015 · HL · contact PI
High Content Sceening for Hereditary Stroke Syndrome$325,938
R01 · FY2015 · NS · contact PI
The Role of the Vasculature in the Pathogenesis of Arthritis$316,625
R01 · FY2015 · AR · contact PI
Training in Cardiovascular Research$468,039
T32 · FY2014 · HL · contact PI
Endothelial Toll-Like Receptor Signaling and Inflammation$372,500
R01 · FY2014 · HL · contact PI
Opposing Mechanisms of Stabilizing and Destabilizing Receptors$365,050
R01 · FY2014 · HL · contact PI
High Content Sceening for Hereditary Stroke Syndrome$322,678
R01 · FY2014 · NS · contact PI
The Role of the Vasculature in the Pathogenesis of Arthritis$316,625
R01 · FY2014 · AR · contact PI
The Development of Screening Assays For Novel Inhibitors Of ARNO And Its Effector$295,552
R01 · FY2014 · CA · contact PI
Training in Cardiovascular Research$532,114
T32 · FY2013 · HL · contact PI
Opposing Mechanisms of Stabilizing and Destabilizing Receptors$354,818
R01 · FY2013 · HL · contact PI
Vascular Malformations of the CNS$353,142
R01 · FY2013 · HL · contact PI
Novel vascular guidance mechanisms$352,252
R01 · FY2013 · HL · contact PI
Vascular stabilization as a broad theraprutic platform for biodefense$349,305
U54 · FY2013 · AI · contact PI
High Content Sceening for Hereditary Stroke Syndrome$325,938
R01 · FY2013 · NS · contact PI
The Role of the Vasculature in the Pathogenesis of Arthritis$316,625
R01 · FY2013 · AR · contact PI
The Development of Screening Assays For Novel Inhibitors Of ARNO And Its Effector$286,412
R01 · FY2013 · CA · contact PI
Training in Cardiovascular Research$532,114
T32 · FY2012 · HL · contact PI
Vascular stabilization as a broad theraprutic platform for biodefense$377,639
U54 · FY2012 · AI · contact PI
Vascular Malformations of the CNS$371,896
R01 · FY2012 · HL · contact PI
Novel vascular guidance mechanisms$370,013
R01 · FY2012 · HL · contact PI
The Development of Screening Assays For Novel Inhibitors Of ARNO And Its Effector$317,705
R01 · FY2012 · CA · contact PI
Vevo 2100 Imaging System (120V)$443,980
S10 · FY2011 · RR · contact PI
Training in Cardiovascular Research$391,579
T32 · FY2011 · HL · contact PI
Vascular Malformations of the CNS$375,826
R01 · FY2011 · HL · contact PI
Utilizing human genetics to understand endothelial barrier function$373,750
R01 · FY2011 · HL · contact PI
Vascular stabilization as a broad theraprutic platform for biodefense$340,991
U54 · FY2011 · AI · contact PI
Vascular stabilization as a broad theraprutic platform for biodefense$381,937
U54 · FY2010 · AI · contact PI
Vascular Malformations of the CNS$377,744
R01 · FY2010 · HL · contact PI
Novel vascular guidance mechanisms$376,250
R01 · FY2010 · HL · contact PI
Netrins in vascular and Stem cell guidance$376,250
R01 · FY2010 · HL · contact PI
Utilizing human genetics to understand endothelial barrier function$373,750
R01 · FY2010 · HL · contact PI
Vascular Malformations of the CNS$390,369
R01 · FY2009 · HL · contact PI
Netrins in vascular and Stem cell guidance$376,250
R01 · FY2009 · HL · contact PI
Novel vascular guidance mechanisms$376,250
R01 · FY2009 · HL · contact PI
Utilizing human genetics to understand endothelial barrier function$373,750
R01 · FY2009 · HL · contact PI
Vascular stabilization as a broad theraprutic platform for biodefense$330,788
U54 · FY2009 · AI · contact PI
Training in Cardiovascular Research$1
T32 · FY2009 · HL · contact PI
Netrins in vascular and Stem cell guidance$376,250
R01 · FY2008 · HL · contact PI
Utilizing human genetics to understand endothelial barrier function$373,750
R01 · FY2008 · HL · contact PI
Netrins in vascular and Stem cell guidance$373,750
R01 · FY2007 · HL · contact PI
New vascular guidance signaling pathway$318,945
R01 · FY2007 · HL · contact PI
New vascular guidance signaling pathway$328,471
R01 · FY2006 · HL · contact PI
Molecular basis for vascular malformations$107,730
K02 · FY2006 · HL · contact PI
Elastin matrix model of obstructive vascular disease$373,750
R01 · FY2005 · HL
New vascular guidance signaling pathway$336,375
R01 · FY2005 · HL
Molecular basis for vascular malformations$107,730
K02 · FY2005 · HL
Elastin matrix model of obstructive vascular disease$373,750
R01 · FY2004 · HL
New vascular guidance signaling pathway$336,375
R01 · FY2004 · HL
Molecular basis for vascular malformations$107,730
K02 · FY2004 · HL
Elastin matrix model of obstructive vascular disease$373,750
R01 · FY2003 · HL
ROLE OF A1KL IN VESSEL IDENTITY AND VASCULAR DISEASE$262,500
R01 · FY2003 · HL
Molecular basis for vascular malformations$107,730
K02 · FY2003 · HL
Elastin matrix model of obstructive vascular disease$375,000
R01 · FY2002 · HL
ROLE OF A1KL IN VESSEL IDENTITY AND VASCULAR DISEASE$262,500
R01 · FY2002 · HL
Molecular basis for vascular malformations$107,730
K02 · FY2002 · HL
ROLE OF A1KL IN VESSEL IDENTITY AND VASCULAR DISEASE$262,500
R01 · FY2001 · HL
ROLE OF A1KL IN VESSEL IDENTITY AND VASCULAR DISEASE$286,625
R01 · FY2000 · HL
ELASTIN AND THE PATHOGENESIS OF VASCULAR DISEASE$124,200
K08 · FY2000 · HL